Table II. Comparison of the responses to Epo of 2fTGH cells stably expressing the chimeric receptors with those induced through the endogenous receptors by IFN-γ and IL-6.
Receptor | Ligand | JAK activationa | STAT1 activation | IRF-1 mRNA | IFN-γ-inducible mRNAs | Class II HLAb | Antiviral response |
---|---|---|---|---|---|---|---|
Eg | Epo | + | + (T)c | + (T)c | – | – | – |
EgΔB | Epo | + | –d | – | – | – | – |
EgΔBY440 | Epo | + | + | + | + | + | + |
EgΔBY905 | Epo | + | + | + | + | + | + |
IFN-γ | IFN-γ | + | + | + | + | + | + |
IL-6 | IL-6 | + | + (T)c | + (T)c | – | – | – |
aJAKs1 and 2 for IFN-γ and JAKs1, 2 and Tyk2 for remainder.
bmRNA (RNase protection) for all receptors and cell surface protein (FACS) for EgΔBY440/905, IFN-γ and IL-6.
c (T), transient.
dBarely detectable by EMSA.